150 N. RADNOR CHESTER ROAD, RADNOR, PA
Material disclosure
Announces Pricing of $150 Million Underwritten Offering of Common Stock
2026 Annual Meeting Results; Three Directors Elected for Three-Year Terms
Reports First Quarter 2026 Financial Results and Provides Corporate Update
Annual Report to Security Holders
Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update
Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Q1
Q3
Q2
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
S-3ASR
Registration Statement for Additional Securities
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence